Your browser doesn't support javascript.
loading
Anti-SARS-CoV-2 IgA Identifies Asymptomatic Infection in First Responders.
Montague, Brian T; Wipperman, Matthew F; Hooper, Andrea T; Hamon, Sara C; Crow, Rowena; Elemo, Femi; Hersh, Lisa; Langdon, Shaun; Hamilton, Jennifer D; O'Brien, Meagan P; Simões, Eric A F.
Affiliation
  • Montague BT; University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Wipperman MF; Regeneron Pharmaceuticals, Tarrytown, New York, USA.
  • Hooper AT; Regeneron Pharmaceuticals, Tarrytown, New York, USA.
  • Hamon SC; Regeneron Pharmaceuticals, Tarrytown, New York, USA.
  • Crow R; University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Elemo F; Regeneron Pharmaceuticals, Tarrytown, New York, USA.
  • Hersh L; Regeneron Pharmaceuticals, Tarrytown, New York, USA.
  • Langdon S; Regeneron Pharmaceuticals, Tarrytown, New York, USA.
  • Hamilton JD; Regeneron Pharmaceuticals, Tarrytown, New York, USA.
  • O'Brien MP; Regeneron Pharmaceuticals, Tarrytown, New York, USA.
  • Simões EAF; University of Colorado School of Medicine, Aurora, Colorado, USA.
J Infect Dis ; 225(4): 578-586, 2022 02 15.
Article in En | MEDLINE | ID: mdl-34636907

Full text: 1 Database: MEDLINE Main subject: Immunoglobulin A / Asymptomatic Infections / Emergency Responders / COVID-19 / Antibodies, Viral Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Infect Dis Year: 2022 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Immunoglobulin A / Asymptomatic Infections / Emergency Responders / COVID-19 / Antibodies, Viral Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Infect Dis Year: 2022 Type: Article Affiliation country: United States